BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23117977)

  • 1. The COPD control panel: towards personalised medicine in COPD.
    Agusti A; MacNee W
    Thorax; 2013 Jul; 68(7):687-90. PubMed ID: 23117977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine--a critical view.
    Lopez-Campos JL; Bustamante V; Muñoz X; Barreiro E
    COPD; 2014 Sep; 11(5):591-602. PubMed ID: 24914771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global assessment of the COPD patient: time to look beyond FEV1?
    Papaioannou AI; Loukides S; Gourgoulianis KI; Kostikas K
    Respir Med; 2009 May; 103(5):650-60. PubMed ID: 19167871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?
    Vestbo J; Hurd SS; Rodriguez-Roisin R
    Clin Respir J; 2012 Oct; 6(4):208-14. PubMed ID: 22906068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The path to personalised medicine in COPD.
    Agusti A
    Thorax; 2014 Sep; 69(9):857-64. PubMed ID: 24781218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and management of chronic obstructive pulmonary disease].
    Sato N; Kanazawa M
    Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung function test for COPD].
    Itabashi S
    Nihon Rinsho; 2003 Dec; 61(12):2150-7. PubMed ID: 14674325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
    Jones PW; Agusti AG
    Eur Respir J; 2006 Apr; 27(4):822-32. PubMed ID: 16585091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic and treatment of chronic obstructive pulmonary disease based on GOLD statement 2011].
    Barczyk A; Pierzchała W
    Pol Merkur Lekarski; 2012 Oct; 33(196):187-92. PubMed ID: 23272604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice.
    van der Molen T; Diamant Z; Kocks JW; Tsiligianni IG
    Expert Rev Respir Med; 2014 Aug; 8(4):479-91. PubMed ID: 24894492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2007 GOLD Guidelines: a comprehensive care framework.
    Gold PM
    Respir Care; 2009 Aug; 54(8):1040-9. PubMed ID: 19650945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease.
    Celli BR; Calverley PM; Rennard SI; Wouters EF; Agusti A; Anthonisen N; Macnee W; Jones P; Pride N; Rodriguez-Roisin R; Rossi A; Wanner A
    Respir Med; 2005 Dec; 99(12):1546-54. PubMed ID: 16291077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
    Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
    Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severity of COPD--a broader prognostic assessment is necessary].
    Puhan M
    Praxis (Bern 1994); 2007 Nov; 96(48):1901-5. PubMed ID: 18072580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD exacerbations . 3: Pathophysiology.
    O'Donnell DE; Parker CM
    Thorax; 2006 Apr; 61(4):354-61. PubMed ID: 16565268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.
    Zuwallack RL; Nici L
    COPD; 2012 Dec; 9(6):637-48. PubMed ID: 22958136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complexity in chronic obstructive pulmonary disease. Individualized treatment, new approaches, phenotypes and comorbidities].
    Martín-Escudero JC
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():13-21. PubMed ID: 21596169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
    Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
    Garcia-Aymerich J; Gómez FP; Benet M; Farrero E; Basagaña X; Gayete À; Paré C; Freixa X; Ferrer J; Ferrer A; Roca J; Gáldiz JB; Sauleda J; Monsó E; Gea J; Barberà JA; Agustí À; Antó JM;
    Thorax; 2011 May; 66(5):430-7. PubMed ID: 21177668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.